Literature DB >> 27924092

Response to Cote-Daigneaut et al.

Ryan Ungaro1, Helena L Chang2, Jean-Frederic Colombel1.   

Abstract

Year:  2016        PMID： 27924092     DOI： 10.1038/ajg.2016.457

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

Review 1.  Potential Immunomodulatory Effects of Statins in Inflammatory Bowel Disease.

Authors:  Justin Côté-Daigneault; Saurabh Mehandru; Ryan Ungaro; Ashish Atreja; Jean-Frédéric Colombel
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

2.  Comparison of frequency of inflammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers.

Authors:  Dina Khalil; Moheb Boktor; Eric M Mortensen; Christopher R Frei; Ishak Mansi
Journal:  Am J Cardiol       Date:  2015-02-18       Impact factor: 2.778

3.  Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study.

Authors:  Seth D Crockett; Richard A Hansen; Til Stürmer; Robin Schectman; Jane Darter; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2011-08-08       Impact factor: 5.325

4.  Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.

Authors:  Olof Grip; Sabina Janciauskiene
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.